Medical Weight Loss for Buffalo, New York Residents
Buffalo, New York residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Buffalo through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Buffalo Residents Choose New Hope Weight Loss
Buffalo patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across New York and beyond since 2020.
Buffalo and Western New York are served through telehealth from our Costa Mesa, California clinic. The full program runs by secure video, with compounded medication shipped to your Buffalo address.
Buffalo is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout Downtown, Elmwood Village, Allentown, North Buffalo, and the greater Western New York area. There is no distance surcharge for Buffalo patients, and HSA, FSA, Klarna, and Affirm are all accepted.
Like much of New York, many people in Buffalo want a physician-supervised weight-loss option without local waitlists or unclear pricing. Compounded medication arrives in discreet, cold-pack packaging at your Buffalo address, usually within days.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Buffalo
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Buffalo
Step 1: Complete the 2-minute quiz or the medical intake form online.
Step 2: Dr. Sharma reviews your history by secure video, typically within 48 hours.
Step 3: If you are a candidate and telehealth-eligible, the state-licensed 503(a) pharmacy ships your compounded medication to your Buffalo address in cold-pack packaging. Follow-ups and dose adjustments also happen by video, no travel required.
Frequently Asked Questions, Buffalo
Does New Hope Weight Loss treat patients in Buffalo?
Yes. Although the clinic is in Costa Mesa, California, we treat Buffalo, New York residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Buffalo?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Buffalo address in cold-pack packaging.
What do Buffalo patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Buffalo do you serve?
We serve patients from across Buffalo by telehealth, including Downtown, Elmwood Village, Allentown, North Buffalo, and the greater Western New York area.
How is medication shipped to Buffalo patients?
After Dr. Sharma approves your protocol, the state-licensed 503(a) compounding pharmacy ships compounded semaglutide or tirzepatide directly to your Buffalo address in cold-pack packaging. There is no distance surcharge.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Buffalo, New York by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.